Patents Assigned to USA Universe Bioengineering, Inc.
  • Fusion proteins comprising IFN-alpha2b and TM-alpha1
    Patent number: 6319691
    Abstract: A fusion protein which comprises human IFN-alpha2b and human TM-alpha1. Such fusion proteins have enhanced biological activity and are useful for the treatment of viral, neoplastic and immunodeficiency diseases.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: November 20, 2001
    Assignee: USA Universe Bioengineering, Inc.
    Inventor: Danny Zhong Der Pang
  • Retro-inverso thymosin alpha 1 hybrids
    Patent number: 6204360
    Abstract: Retro-inverso thymosin alpha 1 and its hybrids, native/retro-inverso thymosin alpha 1, possess the characteristics of greater stability and activity than their parent thymosin alpha 1. Such novel analogs and hybrids are useful for therapeutic purposes in viral, neoplastic and immunodeficiency diseases.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: March 20, 2001
    Assignee: USA Universe Bioengineering, Inc.
    Inventor: Danny Zhong Der Pang